Molecular Dynamics Simulation of SARS-CoV-2 E Ion Channel : The Study of Lone Protein and its Conformational Changes in Complex with Potential Cage Inhibitors
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
BACKGROUND: The coronavirus E ion channel has previously been studied as a potential target for antiviral therapy, with several compounds found to bind to the channel. However, these compounds have low activity, searching for effective E ion channel inhibitors of great importance.
OBJECTIVE: This study aimed to develop a computational approach for designing ligands for the coronaviral E ion channel and identify potential inhibitors based on this approach.
METHODS: The structure of the E-ion channel was refined using molecular dynamics, and the pore responsible for binding cage compounds was selected as the inhibitor-binding site. Potential inhibitor structures were identified using molecular docking, and their binding was confirmed using molecular dynamics simulations.
RESULTS: A number of potential SARS E ion channel inhibitors have been identified, and the binding modes and possible mechanisms of action of these inhibitors have been clarified.
CONCLUSION: This study presents a computational approach that can be used to design ligands for E ion channels and identify potential inhibitors, providing valuable insights into the development of new antiviral therapies. The behavior of the E protein pentamer of SARS-CoV-2 in its native environment was investigated using Molecular Dynamics (MD), resulting in an equilibrated structure that could be used to develop new inhibitors through molecular docking. Simulation of the MD of E-channel complexes with amantadine analogues allowed for the identification of the main types of ligand-protein interactions that are responsible for the good binding of ligands within the channel's inner chamber.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Current computer-aided drug design - (2024) vom: 05. Apr. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shiryaev, Vadim Andreevich [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adamantanes. |
---|
Anmerkungen: |
Date Revised 09.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.2174/0115734099247899240326073802 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370805577 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370805577 | ||
003 | DE-627 | ||
005 | 20240409233403.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240409s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2174/0115734099247899240326073802 |2 doi | |
028 | 5 | 2 | |a pubmed24n1370.xml |
035 | |a (DE-627)NLM370805577 | ||
035 | |a (NLM)38591205 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shiryaev, Vadim Andreevich |e verfasserin |4 aut | |
245 | 1 | 0 | |a Molecular Dynamics Simulation of SARS-CoV-2 E Ion Channel |b The Study of Lone Protein and its Conformational Changes in Complex with Potential Cage Inhibitors |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 09.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
520 | |a BACKGROUND: The coronavirus E ion channel has previously been studied as a potential target for antiviral therapy, with several compounds found to bind to the channel. However, these compounds have low activity, searching for effective E ion channel inhibitors of great importance | ||
520 | |a OBJECTIVE: This study aimed to develop a computational approach for designing ligands for the coronaviral E ion channel and identify potential inhibitors based on this approach | ||
520 | |a METHODS: The structure of the E-ion channel was refined using molecular dynamics, and the pore responsible for binding cage compounds was selected as the inhibitor-binding site. Potential inhibitor structures were identified using molecular docking, and their binding was confirmed using molecular dynamics simulations | ||
520 | |a RESULTS: A number of potential SARS E ion channel inhibitors have been identified, and the binding modes and possible mechanisms of action of these inhibitors have been clarified | ||
520 | |a CONCLUSION: This study presents a computational approach that can be used to design ligands for E ion channels and identify potential inhibitors, providing valuable insights into the development of new antiviral therapies. The behavior of the E protein pentamer of SARS-CoV-2 in its native environment was investigated using Molecular Dynamics (MD), resulting in an equilibrated structure that could be used to develop new inhibitors through molecular docking. Simulation of the MD of E-channel complexes with amantadine analogues allowed for the identification of the main types of ligand-protein interactions that are responsible for the good binding of ligands within the channel's inner chamber | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Coronavirus | |
650 | 4 | |a E ion channel | |
650 | 4 | |a adamantanes. | |
650 | 4 | |a cage compounds | |
650 | 4 | |a molecular docking | |
650 | 4 | |a molecular dynamics | |
700 | 1 | |a Ivleva, Elena Alexandrovna |e verfasserin |4 aut | |
700 | 1 | |a Zaborskaya, Maria Sergeevna |e verfasserin |4 aut | |
700 | 1 | |a Tkachenko, Ilya Michailovich |e verfasserin |4 aut | |
700 | 1 | |a Osyanin, Vitaly Alexandrovich |e verfasserin |4 aut | |
700 | 1 | |a Klimochkin, Yuri Nikolaevich |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current computer-aided drug design |d 2008 |g (2024) vom: 05. Apr. |w (DE-627)NLM191691046 |x 1875-6697 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:05 |g month:04 |
856 | 4 | 0 | |u http://dx.doi.org/10.2174/0115734099247899240326073802 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 05 |c 04 |